title: New pain drugs in pipeline, but challenges to usage remain.
authors.forename: Vicki
authors.initials: V
authors.lastname: Brower
mesh_terms: D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002185:Cannabidiol; D002186:Cannabinoids / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D013759:Dronabinol; D004338:Drug Combinations; D015507:Drugs, Investigational / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D009437:Neuralgia / Q000188:drug therapy / Q000209:etiology; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology*; D010166:Palliative Care / Q000331:legislation & jurisprudence / Q000379:methods; D010936:Plant Extracts / Q000494:pharmacology
chemical_list: D000700:Analgesics; D000701:Analgesics, Opioid; D000970:Antineoplastic Agents; D002186:Cannabinoids; D004338:Drug Combinations; D015507:Drugs, Investigational; D010936:Plant Extracts; D002185:Cannabidiol; D013759:Dronabinol; C587251:nabiximols